327 related articles for article (PubMed ID: 20386556)
1. Imaging ovarian cancer and peritoneal metastases--current and emerging techniques.
Kyriazi S; Kaye SB; deSouza NM
Nat Rev Clin Oncol; 2010 Jul; 7(7):381-93. PubMed ID: 20386556
[TBL] [Abstract][Full Text] [Related]
2. MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients.
Engbersen MP; Van' T Sant I; Lok C; Lambregts DMJ; Sonke GS; Beets-Tan RGH; van Driel WJ; Lahaye MJ
Eur J Radiol; 2019 May; 114():146-151. PubMed ID: 31005166
[TBL] [Abstract][Full Text] [Related]
3. Imaging for Peritoneal Metastases.
Low RN; Barone RM
Surg Oncol Clin N Am; 2018 Jul; 27(3):425-442. PubMed ID: 29935681
[TBL] [Abstract][Full Text] [Related]
4. Molecular Imaging of Peritoneal Carcinomatosis in Ovarian Carcinoma.
Lee EYP; An H; Tse KY; Khong PL
AJR Am J Roentgenol; 2020 Aug; 215(2):305-312. PubMed ID: 32551907
[No Abstract] [Full Text] [Related]
5. Diffusion-Weighted Imaging of Small Peritoneal Implants in "Potentially" Early-Stage Ovarian Cancer.
Grabowska-Derlatka L; Derlatka P; Szeszkowski W; Cieszanowski A
Biomed Res Int; 2016; 2016():9254742. PubMed ID: 27022614
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings.
Garcia Prado J; González Hernando C; Varillas Delgado D; Saiz Martínez R; Bhosale P; Blazquez Sanchez J; Chiva L
Eur J Radiol; 2019 Dec; 121():108696. PubMed ID: 31683251
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of imaging (ultrasonography, doppler, CT, MR, PET-CT) for the diagnosis of a suspicious ovarian mass and staging of ovarian, tubal or primary peritoneal cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Thomassin-Naggara I; Daraï E; Lécuru F; Fournier L
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):123-133. PubMed ID: 30686729
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.
Drieskens O; Stroobants S; Gysen M; Vandenbosch G; Mortelmans L; Vergote I
Gynecol Obstet Invest; 2003; 55(3):130-4. PubMed ID: 12865590
[TBL] [Abstract][Full Text] [Related]
9. Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index.
Diaz-Gil D; Fintelmann FJ; Molaei S; Elmi A; Hedgire SS; Harisinghani MG
Abdom Radiol (NY); 2016 Nov; 41(11):2196-2202. PubMed ID: 27338731
[TBL] [Abstract][Full Text] [Related]
10. Multidetector computed tomography in diagnosing peritoneal metastases in ovarian carcinoma.
Tsili AC; Naka C; Argyropoulou MI
Acta Radiol; 2021 Dec; 62(12):1696-1706. PubMed ID: 33334121
[TBL] [Abstract][Full Text] [Related]
11. Validation of
Jónsdóttir B; Ripoll MA; Bergman A; Silins I; Poromaa IS; Ahlström H; Stålberg K
Cancer Imaging; 2021 Apr; 21(1):34. PubMed ID: 33849649
[TBL] [Abstract][Full Text] [Related]
12. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal carcinomatosis: role of (18)F-FDG PET.
Turlakow A; Yeung HW; Salmon AS; Macapinlac HA; Larson SM
J Nucl Med; 2003 Sep; 44(9):1407-12. PubMed ID: 12960184
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging.
Iafrate F; Ciolina M; Sammartino P; Baldassari P; Rengo M; Lucchesi P; Sibio S; Accarpio F; Di Giorgio A; Laghi A
Abdom Imaging; 2012 Aug; 37(4):616-27. PubMed ID: 21972153
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of pre-treatment FDG-PET/CT staging of primary ovarian, fallopian tube, and peritoneal cancers in women.
Sponholtz SE; Mogensen O; Hildebrandt MG; Jensen PT
Acta Obstet Gynecol Scand; 2020 Feb; 99(2):186-195. PubMed ID: 31505027
[TBL] [Abstract][Full Text] [Related]
16. The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis.
An H; Lee EYP; Chiu K; Chang C
Clin Radiol; 2018 Jul; 73(7):597-609. PubMed ID: 29685803
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer.
Gryspeerdt S; Clabout L; Van Hoe L; Berteloot P; Vergote IB
Eur J Gynaecol Oncol; 1998; 19(5):434-7. PubMed ID: 9863905
[TBL] [Abstract][Full Text] [Related]
18. CT of ovarian cancer: 3D cinematic rendering for preoperative evaluation.
Jin YR; Yang XL; Li QQ; Yan ZL; Yang HY; Liao C
J Ovarian Res; 2018 Sep; 11(1):86. PubMed ID: 30257720
[TBL] [Abstract][Full Text] [Related]
19. Imaging in the pre-operative staging of ovarian cancer.
Castellani F; Nganga EC; Dumas L; Banerjee S; Rockall AG
Abdom Radiol (NY); 2019 Feb; 44(2):685-696. PubMed ID: 30229424
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC).
Mazzei MA; Khader L; Cirigliano A; Cioffi Squitieri N; Guerrini S; Forzoni B; Marrelli D; Roviello F; Mazzei FG; Volterrani L
Abdom Imaging; 2013 Dec; 38(6):1422-30. PubMed ID: 23744439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
